Related Experiment Video
Updated: Jun 6, 2025

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
Leveraging Cancer Therapy Peptide Data: A Case Study on Machine Learning Application in Accelerating Cancer Research
Georgios Feretzakis1, Athanasios Anastasiou2, Stavros Pitoglou3
1School of Science and Technology, Hellenic Open University, Patras, Greece.
Abstract:
This study leverages the DCTPep database, a comprehensive repository of cancer therapy peptides, to explore the application of machine learning in accelerating cancer research. We applied Principal Component Analysis (PCA) and K-means clustering to categorize cancer therapy peptides based on their physicochemical properties. Our analysis identified three distinct clusters, each characterized by unique features such as sequence length, isoelectric point (pI), net charge, and mass. These findings provide valuable insights into the key properties that influence peptide efficacy, offering a foundation for the design of new therapeutic peptides. Future work will focus on experimental validation and the integration of additional data sources to refine the clustering and enhance the predictive power of the model, ultimately contributing to the development of more effective peptide-based cancer treatments.
More Related Videos
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy